Company Filing History:
Years Active: 2012
Title: **Innovator Sang-Hoon Ha: Advancing mTOR Research in Pohang, South Korea**
Introduction
Sang-Hoon Ha is a prominent inventor based in Pohang, South Korea. He has made significant contributions to the field of biomedical research, particularly in understanding the regulation of mammalian target-of-rapamycin (mTOR), which plays a crucial role in cellular growth and metabolism. With two patents to his name, he is working diligently to develop innovative solutions for mTOR-related metabolic diseases.
Latest Patents
Sang-Hoon Ha's latest patents include groundbreaking methods for regulating mTOR activity. His first patent, titled "Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor," focuses on a method of modulating mTOR activity through the regulation of phospholipase D (PLD). This invention not only presents a novel approach to controlling mTOR but also proposes a method for screening inhibitors of mTOR, paving the way for potential treatments for mTOR-related metabolic diseases.
The second patent, "Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and Rheb," uncovers a new regulatory mechanism involving PLD and Ras homolog enriched in brain (Rheb). Similar to his first patent, this invention outlines methods for screening mTOR inhibitors and explores therapeutic compositions aimed at treating metabolic disorders linked to mTOR dysfunction.
Career Highlights
Sang-Hoon Ha is affiliated with the Postech Academy-Industry Foundation, where he leverages his expertise to explore innovative research avenues. His work has been instrumental in advancing the understanding of mTOR pathways, which are critical in various physiological processes.
Collaborations
Throughout his career, Sang-Hoon Ha has collaborated with notable colleagues, including Sung-Ho Ryu and Pann-Ghill Suh. These collaborations have fostered a rich exchange of ideas and have contributed to the success of his research endeavors.
Conclusion
Sang-Hoon Ha stands out as a dedicated inventor in the biomedical field, with a focus on addressing metabolic diseases through mTOR regulation. His innovative patents reflect a deep commitment to advancing research and developing effective treatments that may significantly impact public health. With ongoing collaborations and an impressive body of work, Sang-Hoon Ha is poised to make further contributions to scientific knowledge and the advancement of medical therapies.